Your browser doesn't support javascript.
Polypharmacy Exposure, Aging Populations, and COVID-19: Considerations for Healthcare Providers and Public Health Practitioners in Africa.
Nwanaji-Enwerem, Jamaji C; Boyer, Edward W; Olufadeji, Ayobami.
  • Nwanaji-Enwerem JC; Gangarosa Department of Environmental Health, Emory Rollins School of Public Health, Atlanta, GA 30322, USA.
  • Boyer EW; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Olufadeji A; Department of Emergency Medicine, Division of Medical Toxicology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Int J Environ Res Public Health ; 18(19)2021 Sep 29.
Article in English | MEDLINE | ID: covidwho-1444200
ABSTRACT
Given the continent's growing aging population and expanding prevalence of multimorbidity, polypharmacy is an increasingly dire threat to the health of persons living in Africa. The COVID-19 pandemic has only exacerbated these issues. Widespread misinformation, lack of vaccine access, and attempts to avoid being infected have resulted in increases in Africans' willingness to take multiple prescription and nonprescription medications and supplements. Issues with counterfeit pharmaceuticals and the relatively new recognition of emergency medicine as a specialty across the continent also create unique challenges for addressing this urgent public health need. Experts have called for more robust pharmaceutical regulation and healthcare/public health infrastructure investments across the continent. However, these changes take time, and more near-term strategies are needed to mitigate current health needs. In this commentary, we present a nonexhaustive set of immediately implementable recommendations that can serve as local strategies to address current polypharmacy-related health needs of Africans. Importantly, our recommendations take into consideration that not all healthcare providers are emergency medicine trained and that local trends related to polypharmacy will change over time and require ever-evolving public health initiatives. Still, by bolstering training to safeguard against provider availability biases, practicing evidence-based prescribing and shared decision making, and tracking and sharing local trends related to polypharmacy, African healthcare providers and public health practitioners can better position themselves to meet population needs. Furthermore, although these recommendations are tailored to Africans, they may also prove useful to providers and practitioners in other regions facing similar challenges.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Polypharmacy / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Aged / Humans Language: English Year: 2021 Document Type: Article Affiliation country: Ijerph181910263

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Polypharmacy / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Aged / Humans Language: English Year: 2021 Document Type: Article Affiliation country: Ijerph181910263